- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT02563158
Study of Liver Resection With Versus Without Hepatic Inflow Occlusion for the HBV-related HCC (OHx-NOHx)
Short- and Long-term Outcomes of Liver Resection With Versus Without Hepatic Inflow Occlusion for the Hepatitis B Virus-related Hepatocellular Carcinoma: a Prospective Randomized Controlled Trial
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
High prevalence of hepatitis B virus (HBV) imposes a huge burden of hepatocellular carcinoma (HCC) in Asia. Liver resection remains the mainstay of treatment for HCC. Hepatic inflow occlusion, known as the Pringle maneuver, is most commonly used to reduce blood loss during liver parenchymal transection. A major issue about this maneuver is the ischemia-reperfusion injury to the remnant liver. And the hemodynamic disturbance to the tumor-bearing liver remains an oncologic concern. Given the technical advances in living donor liver transplantation, vascular occlusion can be avoided in liver resection by experienced hands. This study aims to compare the perioperative and long-term outcomes of liver resection for HBV-related HCC without versus with hepatic inflow occlusion.
This study will include eligible patients with HBV-related HCC elected for liver resection. 57 patients will be enrolled in each randomized arm to detect a 20% difference in the serum level of total bilirubin on postoperative day 5 (80% power and α = 0.05). The secondary endpoints include procedural parameters, perioperative liver function and inflammatory response, postoperative morbidity and mortality, and long-term outcomes. Patients will be followed for up to five years. Data will be statistically analyzed on an intention-to-treat basis.
This prospective randomized controlled trial is designed to evaluate the feasibility of liver resections for HBV-related HCC without vascular occlusion. Clinical implication of its outcomes may change the present surgical practice and fill the oncologic gaps therein.
Studientyp
Einschreibung (Voraussichtlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Beijing
-
Beijing, Beijing, China, 100853
- Rekrutierung
- Chinese PLA General Hospital
-
Kontakt:
- Yinzhe Xu, M.D., Ph.D.
- Telefonnummer: 86-10-66936609
- E-Mail: james_hbp@163.com
-
Hauptermittler:
- Shichun Lu, M.D., Ph.D.
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Elective liver resection due to HBV-related HCC with Barcelona-Clinic Liver Cancer (BCLC) staging 0 or A;
- Child-Pugh classified A with or without cirrhosis, or reversed to A from B after conventional therapy;
- Tumors located either in the left or right hemiliver;
- Resection extent was a hemi-hepatectomy or less;
- Informed consent.
Exclusion Criteria:
- Having comorbidity that contraindicates surgery;
- Participation in concurrent interventional trials with interference to this study;
- Eligible for laparoscopic hepatectomy;
- Requiring concomitant procedures, such as digestive, vascular or biliary reconstruction;
- Lack of compliance for treatment or future follow-up.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
---|---|
Kein Eingriff: Hx with hepatic inflow occlusion
Hepatectomy is carried out using Pringle maneuver in cycles of 15 minutes clamping + 5 minutes unclamping of the hepatoduodenal ligament.
|
|
Experimental: Hx with non-occlusion technique
Hepatectomy without hepatic inflow occlusion (non-occlusion technique)
|
Hepatectomy is carried out without hepatic inflow control.
(non-occlusion technique)
Andere Namen:
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Serum total bilirubin on postoperative day 5
Zeitfenster: 5 days
|
Postoperative liver insufficiency characterized by the serum total bilirubin on POD 5.
|
5 days
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Intraoperative blood loss
Zeitfenster: Entire operation duration
|
Total blood loss from the incision to the closure of abdomen
|
Entire operation duration
|
Requirement of blood transfusion
Zeitfenster: Entire operation duration
|
The amount of intraoperative blood transfusion
|
Entire operation duration
|
Operative time
Zeitfenster: Entire operation duration
|
The time from induction of anesthesia to the closure of abdomen
|
Entire operation duration
|
Postoperative intensive-care unit (ICU) stay
Zeitfenster: Duration of stay in ICU
|
Duration of stay in ICU
|
Duration of stay in ICU
|
Hospital stay
Zeitfenster: Duration of hospital stay
|
Duration of hospital stay
|
Duration of hospital stay
|
Total hospital expenditure
Zeitfenster: Duration of hospital stay
|
Total costs during hospital stay
|
Duration of hospital stay
|
Perioperative systemic inflammatory response
Zeitfenster: an expected average of 7 days
|
Perioperative systemic inflammatory response is characterized by elevated serum level of tumor necrosis factor-α (TNF-α), interleukins (IL)-1α, 2, 6, 8 and 10, procalcitonin (PCT) and C-reactive protein (CRP) at different time points.
|
an expected average of 7 days
|
Postoperative morbi-mortality
Zeitfenster: an expected average of 12 days in hospital
|
Postoperative morbi-mortality is characterized by postoperative complication and its severity based on Clavien-Dindo classification and in-hospital mortality
|
an expected average of 12 days in hospital
|
Long-term oncologic outcomes
Zeitfenster: 5 years after operation
|
1, 3, 5-year tumor recurrence rate
|
5 years after operation
|
Long-term survival
Zeitfenster: 5 years after operation
|
1, 3, 5-year overall survival (OS) and disease (tumor)-free survival (DFS)
|
5 years after operation
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Shichun Lu, MD, PhD, Department of Hepatobiliary Surgery, Chinese PLA General Hospital, 28 Fuxing Road, Haidian, Beijing, 100853, China
Publikationen und hilfreiche Links
Allgemeine Veröffentlichungen
- Llovet JM, Fuster J, Bruix J; Barcelona-Clinic Liver Cancer Group. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl. 2004 Feb;10(2 Suppl 1):S115-20. doi: 10.1002/lt.20034.
- Katz SC, Shia J, Liau KH, Gonen M, Ruo L, Jarnagin WR, Fong Y, D'Angelica MI, Blumgart LH, Dematteo RP. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg. 2009 Apr;249(4):617-23. doi: 10.1097/SLA.0b013e31819ed22f.
- Dong JH, Yang SZ, Duan WD, Ji WB, Cai SW, Wang J, Shi XJ, Jiang K, Xia HT, He L, Zhang WZ, Huang XQ, Huang ZQ. [Clinical application of precise liver resection techniques in patients with complicated liver space-occupying lesions]. Zhonghua Wai Ke Za Zhi. 2009 Nov 1;47(21):1610-5. Chinese.
- Huang ZQ, Xu LN, Yang T, Zhang WZ, Huang XQ, Liu R, Cai SW, Zhang AQ, Feng YQ, Zhou NX, Dong JH. [Liver resection: single center experiences of 2008 consecutive resections in 20 years]. Zhonghua Wai Ke Za Zhi. 2008 Sep 1;46(17):1314-21. Chinese.
- Dong J, Yang S, Zeng J, Cai S, Ji W, Duan W, Zhang A, Ren W, Xu Y, Tan J, Bu X, Zhang N, Wang X, Wang X, Meng X, Jiang K, Gu W, Huang Z. Precision in liver surgery. Semin Liver Dis. 2013 Aug;33(3):189-203. doi: 10.1055/s-0033-1351781. Epub 2013 Aug 13. Danish, English.
- Sugiyama Y, Ishizaki Y, Imamura H, Sugo H, Yoshimoto J, Kawasaki S. Effects of intermittent Pringle's manoeuvre on cirrhotic compared with normal liver. Br J Surg. 2010 Jul;97(7):1062-9. doi: 10.1002/bjs.7039.
- Kim YI, Song KE, Ryeon HK, Hwang YJ, Yun YK, Lee JW, Chun BY. Enhanced inflammatory cytokine production at ischemia/reperfusion in human liver resection. Hepatogastroenterology. 2002 Jul-Aug;49(46):1077-82.
- Fu SY, Lau WY, Li GG, Tang QH, Li AJ, Pan ZY, Huang G, Yin L, Wu MC, Lai EC, Zhou WP. A prospective randomized controlled trial to compare Pringle maneuver, hemihepatic vascular inflow occlusion, and main portal vein inflow occlusion in partial hepatectomy. Am J Surg. 2011 Jan;201(1):62-9. doi: 10.1016/j.amjsurg.2009.09.029. Epub 2010 Apr 20. Erratum In: Am J Surg. 2011 Jul;202(1):117. multiple author names corrected.
- Xu Y, Chen J, Wang H, Zheng H, Feng D, Zhang A, Leng J, Duan W, Yang Z, Chen M, Shi X, Cai S, Ji W, Jiang K, Zhang W, Chen Y, Gu W, Dong J, Lu S. Perioperative and long-term outcomes of liver resection for hepatitis B virus-related hepatocellular carcinoma without versus with hepatic inflow occlusion: study protocol for a prospective randomized controlled trial. Trials. 2016 Oct 11;17(1):492. doi: 10.1186/s13063-016-1621-9.
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Primärer Abschluss (Voraussichtlich)
Studienabschluss (Voraussichtlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Schätzen)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- JFJZYY-GD-15-01
- NO. 2012BAI06B01 (Andere Zuschuss-/Finanzierungsnummer: National Key Technology R&D Program of China)
- NO. 2012ZX10002-017 (Andere Zuschuss-/Finanzierungsnummer: National S&T Major Project for Infectious Diseases of China)
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Chirurgie
-
West China HospitalRekrutierungOn-Pump Valve Surgery oder CABGChina
-
Karolinska InstitutetErsta Hospital, SwedenAbgeschlossenLoopileostomie | Fast-Track-Programm (Enhanced Recovery After Surgery (ERAS))Schweden
-
Europainclinics z.ú.Brno University Hospital; Pavol Jozef Safarik University; Slovak Academy of SciencesAbgeschlossen
-
Universitair Ziekenhuis BrusselMedtronicAbgeschlossenFailed Back Surgery SyndromBelgien
-
Universitair Ziekenhuis BrusselMedtronicAbgeschlossenFailed Back Surgery SyndromBelgien
-
Ziekenhuis Oost-LimburgUnbekanntRückenschmerzen | RückenmarkstimulationBelgien
-
Universitair Ziekenhuis Brusselthe eNose companyAbgeschlossenFailed Back Surgery SyndromBelgien
-
Moens MaartenAbgeschlossenFailed Back Surgery SyndromBelgien
-
Universitair Ziekenhuis BrusselNevroAbgeschlossenFailed Back Surgery SyndromBelgien
-
Moens MaartenMedtronicAbgeschlossen
Klinische Studien zur non-occlusion technique
-
Nitiloop Ltd.AbgeschlossenKoronare OkklusionIsrael, Vereinigtes Königreich, Polen
-
Penumbra Inc.AbgeschlossenIntrakranielles AneurysmaVereinigte Staaten, Kanada
-
EPD Solutions, A Philips CompanyAbgeschlossenAbtragung | Lichthof; FlimmernBelgien, Vereinigte Staaten
-
Dartmouth-Hitchcock Medical CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... und andere MitarbeiterAktiv, nicht rekrutierendKindheitsfettleibigkeitVereinigte Staaten
-
Ziv HospitalHillel Yafe MC HaderaAbgeschlossenChronische Hepatitis-C-VirusinfektionIsrael
-
AstraZenecaAbgeschlossenBrustkrebs | Onkologie | EpidemiologieAlgerien
-
Pontificia Universidad Catolica de ChileFondo Nacional de Desarrollo Científico y Tecnológico, ChileUnbekannt
-
Moorfields Eye Hospital NHS Foundation TrustAbgeschlossenMakulaloch in voller DickeVereinigtes Königreich
-
Catharina Ziekenhuis EindhovenAbgeschlossen
-
University of UtahAbgeschlossenRisikoschwangerschaftVereinigte Staaten